Fezotan Tablet 45 mg contains Fezolinetant, a modern, non‑hormonal medication designed to treat vasomotor symptoms associated with menopause, particularly hot flashes (hot flushes) and night sweats in adult women. As a selective neurokinin 3 (NK3) receptor antagonist, Fezolinetant offers relief by targeting the neurological pathways that cause temperature dysregulation without the use of estrogen or other hormones. This makes Fezotan a valuable option for women seeking relief from menopausal symptoms who are unable or prefer not to use hormone‑based therapies.
Fezolinetant has been studied extensively and approved in several regions for daily oral use. Typically taken once daily as a 45 mg tablet, Fezotan helps reduce both the frequency and severity of moderate to severe vasomotor symptoms, improving comfort and quality of life during menopause.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Fezotan Tablet 45 mg is indicated for:
Relief of moderate to severe vasomotor symptoms (VMS) such as hot flashes and night sweats due to menopause
Management of thermoregulatory symptoms in postmenopausal women seeking non‑hormonal treatment
Fezolinetant works by selectively blocking the neurokinin 3 (NK3) receptors in the hypothalamus, which is the area of the brain responsible for maintaining body temperature. By inhibiting neurokinin B (NKB) from binding to these receptors, Fezolinetant helps stabilize the body’s temperature regulation pathways, thereby reducing the occurrence and severity of hot flashes and night sweats. This non‑hormonal mechanism makes Fezotan an alternative to estrogen‑based therapies, particularly for women who cannot use hormonal treatments.
Fezotan Tablet 45 mg should be taken as directed by a healthcare professional:
Adults: 45 mg (one tablet) orally once daily, with or without food
Administration: Swallow the tablet whole with water; do not crush or chew
Before starting therapy, baseline liver function tests are recommended, and periodic monitoring should continue during treatment to detect any potential liver abnormalities.
Provides effective relief from menopausal hot flashes and night sweats without hormones
Non‑hormonal therapy suitable for women who cannot or prefer not to use hormone replacement
Once‑daily oral tablet for convenience and compliance
Helps improve overall quality of life by reducing disruptive vasomotor symptoms
Developed based on robust clinical evidence and pharmacological studies
Fezotan Tablet is generally well tolerated, but some women may experience side effects. The most commonly reported include:
Diarrhea
Insomnia (sleep disturbances)
Abdominal or stomach pain
Back pain
Elevated liver enzymes (asymptomatic increases in ALT/AST)
Elevated liver function tests may occur and require monitoring; serious hepatic injury is uncommon but possible. Patients should consult a healthcare provider if they experience signs of liver problems such as jaundice, dark urine, nausea, or abdominal pain.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Liver Monitoring: Liver function should be evaluated before treatment and regularly during therapy due to potential liver enzyme elevations.
Contraindications: Not recommended in women with known cirrhosis or severe renal impairment.
Drug Interactions: Drugs that strongly inhibit CYP1A2 metabolism can increase Fezolinetant levels and are contraindicated.
Pregnancy and Lactation: Fezolinetant is not recommended during pregnancy or breastfeeding due to limited safety data.
Store Fezotan Tablet 45 mg in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.
Fezotan Tablet 45 mg is a modern non‑hormonal option for managing menopausal vasomotor symptoms, offering effective relief and improved quality of life for postmenopausal women when used under medical guidance.
Login Or Registerto submit your questions to seller
No none asked to seller yet